Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelin-positive Advanced Refractory Solid Tumors × fludarabine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Multiple Myeloma 12 Myelodysplastic Syndromes 11 Lymphoma 9 Recurrence 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Large B-Cell, Diffuse 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Lymphoma, B-Cell 6 Myeloproliferative Disorders 5 Lymphoma, Follicular 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Biphenotypic, Acute 5 Leukemia 5 Hodgkin Disease 5 Neoplasms 4 Melanoma 4 Lymphoma, Mantle-Cell 4 Burkitt Lymphoma 4 Pancreatic Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Chronic 3 Hematologic Neoplasms 3 Urogenital Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasm, Residual 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡